share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Mauro David J

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Mauro David J

Recursion Pharmaceuticals | 4：持股變動聲明-高管 Mauro David J
美股SEC公告 ·  08/20 07:13
牛牛AI助理已提取核心訊息
Recursion Pharmaceuticals' Chief Medical Officer, Mauro David J, completed a sale of 14,146 shares of the company's Class A Common Stock on August 15, 2024. The transaction was carried out at a price of $6.69 per share, resulting in a total sale value of $94,636.74. Following the sale, Mauro David J directly holds 229,616 shares in the company. The sale was executed to cover the payment of exercise price or tax liability by delivering or withholding securities, as indicated by the transaction code 'F'.
Recursion Pharmaceuticals' Chief Medical Officer, Mauro David J, completed a sale of 14,146 shares of the company's Class A Common Stock on August 15, 2024. The transaction was carried out at a price of $6.69 per share, resulting in a total sale value of $94,636.74. Following the sale, Mauro David J directly holds 229,616 shares in the company. The sale was executed to cover the payment of exercise price or tax liability by delivering or withholding securities, as indicated by the transaction code 'F'.
Recursion Pharmaceuticals的首席醫學官Mauro David J於2024年8月15日完成了對公司A類普通股的14,146股的銷售。交易價格爲每股6.69美元，總售價爲94636.74美元。銷售後，Mauro David J直接持有公司的229,616股。此次銷售是爲了通過交付或扣除證券來支付行權價格或稅款負債，這是交易代碼'F'所表示的。
Recursion Pharmaceuticals的首席醫學官Mauro David J於2024年8月15日完成了對公司A類普通股的14,146股的銷售。交易價格爲每股6.69美元，總售價爲94636.74美元。銷售後，Mauro David J直接持有公司的229,616股。此次銷售是爲了通過交付或扣除證券來支付行權價格或稅款負債，這是交易代碼'F'所表示的。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間